Compare FEMY & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FEMY | ATCH |
|---|---|---|
| Founded | 2004 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.2M | 34.9M |
| IPO Year | 2021 | 2024 |
| Metric | FEMY | ATCH |
|---|---|---|
| Price | $0.42 | $0.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $5.50 | $1.00 |
| AVG Volume (30 Days) | 548.6K | ★ 2.8M |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.71 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | ★ $2,293,313.00 | N/A |
| Revenue This Year | $105.16 | N/A |
| Revenue Next Year | $200.23 | N/A |
| P/E Ratio | ★ N/A | $4.22 |
| Revenue Growth | ★ 40.77 | N/A |
| 52 Week Low | $0.31 | $0.14 |
| 52 Week High | $1.29 | $1.92 |
| Indicator | FEMY | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 69.47 |
| Support Level | $0.33 | $0.24 |
| Resistance Level | $0.58 | $0.28 |
| Average True Range (ATR) | 0.05 | 0.02 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 72.46 | 93.31 |
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.